Last reviewed · How we verify

NCT04929743

Randomized Clinical Trial to Evaluate the Predictability of 5.5 mm Dental Implants

Completed NA Last updated 25 February 2025
What this trial tests

NA trial testing BTI Implant in Partial-edentulism in 15 participants. Completed in 27 November 2024.

Timeline
11 May 2021
Primary endpoint
27 November 2024
27 November 2024

Quick facts

Lead sponsorFundación Eduardo Anitua
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment15
Start date11 May 2021
Primary completion27 November 2024
Estimated completion27 November 2024
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Fundación Eduardo Anitua — full company profile →

Who can join

18 and older, any sex, with Partial-edentulism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main aim of this clinical trial is to analyze the survival rate of short-length implants (\<4.5 mm) in partial edentulism subjects. 6.5 mm length implants will be used as control arm. Additionally, others clinical parameters (marginal bone loss and prosthetic associated complications) will be measured.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Clinical Performance of Extra-Short (≤5.5 mm) Compared to Longer Implants Splinted under the Same Prosthesis: A Randomized Clinical Trial.
    Anitua E, Montalvillo A, Eguia A, Alkhraisat MH. · · 2024 · cited 1× · PMID 39329858 · DOI 10.3390/dj12090292

Verify or expand the search:

Other trials of BTI Implant

Trials testing the same drug.

Other recruiting trials for Partial-edentulism

Currently open trials in the same condition.

Other Fundación Eduardo Anitua trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04929743.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing